Correlation of BCR/ABL transcript variants with patients' characteristics in childhood chronic myeloid leukaemia

European Journal of Haematology

Volumn 82, Issue 2, 2009, Pages 112-118

  Adler, Ronald ^a   Viehmann, Susanne ^b   Kuhlisch, Eberhard ^a   Martiniak, Yvonne ^a   Röttgers, Silja ^b   Harbott, Jochen ^b   Suttorp, Meinolf ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

b2a2 b3a2 transcripts; BCR ABL transcript; Childhood CML

Indexed keywords

BCR ABL PROTEIN; HEMOGLOBIN; MOLECULAR MARKER;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHILDHOOD LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENETIC TRANSCRIPTION; HEMATOLOGICAL PARAMETERS; HEPATOSPLENOMEGALY; HUMAN; INFANT; LEUKOCYTE COUNT; LEUKOCYTOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE; THROMBOCYTE COUNT;

ADOLESCENT; BASE SEQUENCE; CHILD; CHILD, PRESCHOOL; CHROMOSOME BANDING; COHORT STUDIES; DNA PRIMERS; FEMALE; GENES, ABL; HUMANS; INFANT; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MALE; RNA, MESSENGER; YOUNG ADULT;

EID: 58149383770     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2008.01170.x     Document Type: Article

References (32)

1. Sawyers CL. Chronic myeloid leukaemia. N Engl J Med 1999 340 : 1330 40.
2. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick H, Sultan C, Cox C. The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia. Proposals by the French-American-British Cooperative Leukaemia Group. Br J Haematol 1994 87 : 746 54.
3. Branford S, Hughes TP, Rudzki Z. Dual transcription of b2a2 and b3a2 BCR/ABL transcripts in chronic myeloid leukaemia is confined to patients with a linked polymorphism within the BCR gene. Br J Haematol 2002 117 : 875 7.
4. Meissner RV, Covas DT, Dias PMB, Job F, Leite M, Nardi NB. A polymorphism in exon b2 of the major breakpoint cluster region (M-BCR) identified in chronic myeloid leukaemia patients. Br J Haematol 1998 103 : 224 6.
5. Millot F, Traore P, Guilhot J, Nelken B, Leblanc T, Leverger G, Plantaz D, Bertrand Y, Bordigoni P, Guilhot F. Clinical and biological features at diagnosis in 40 children with chronic myeloid leukemia. Pediatrics 2005 116 : 140 3.
6. Saussele S, Weisser A, Müller MC, Emig M, La Rosée P, Paschka P, Kuhn C, Willer A, Hehlmann R, Hochhaus A. Frequent polymorphism in BCR exon b2 identified in BCR/ABL positive and negative individuals using fluorescent hybridization probes. Leukemia 2000 14 : 2006 10.
7. Bianchi C, Cairoli R, Marenco P, Muti G, Del Monte U, Perego RA. Detection by polymerase chain reaction of BCR/ABL transcripts in myeloproliferative diseases at time of diagnosis and for monitoring chronic myelogenous leukaemia patients after bone marrow transplantation. Eur J Cancer 1995 31A : 197 201.
8. Inokuchi K, Inoue T, Tojo A, et al. A possible correlation between the type of BCR/ABL hybrid messenger RNA and platelet count in Philadelphia-positive chronic myelogenous leukemia. Blood 1991 78 : 3125 7.
9. Perego RA, Costantini M, Cornacchini G, Gargantini L, Bianchi C, Pungolino E, Rovida E, Morra E. The possible influence of b2a2 and b3a2 BCR/ABL protein structure on thrombopoiesis in chronic myeloid leukaemia. Eur J Cancer 2000 36 : 1395 401.
10. Suttorp M on behalf of the EBMT Paediatric Diseases Working Party. Innovative approaches of targeted therapy for chronic myeloid leukaemia of childhood in combination with paediatric haematopoietic stem cell transplantation. Bone Marrow Transplant 2008 42 (Suppl.1 S40 S46.
11. Hasan SK, Sazawal S, Kumar B, Chaubey R, Mishra P, Mir R, Chaudhry VP, Saxena R. Childhood CML in India: b2a2 transcript is more common than b3a2. Cancer Genet Cytogenet 2006 169 : 76 7.
12. Suttorp M, Lion T, Creutzig U, Klingebiel T, Gadner H. Die Behandlung der chronisch myeloischen Leukämie bei Kindern und Jugendlichen - Konzept der mulizentrischen Pilotstudie CML-päd. Klin Pädiatr 1996 208 : 242 9.
13. Suttorp M, Claviez A, Martiniak Y, Klingebiel T, Niethammer D, Gadner H, Peters C, Kabisch H, Henze G, Göbel U. Chronic myeloid leukemia (CML) in childhood - results of the multicenter trial CML-paed. Blood 2004 104 (Suppl. 1 178a 9a. (Abstract).
14. Shaffer LG, Tommerup N, eds. ISCN 2005: An International System for Human Cytogenetic Nomenclature. Basel, Switzerland : S. Karger, 2005.
15. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987 162 : 156 9.
16. Harbott J, Viehmann S, Borkhardt A, Henze G, Lampert F. Incidence of TEL/AML1 fusion gene consecutively analyzed in children with relapse of acute lymphoblastic leukemia (ALL). Blood 1997 90 : 4933 8.
17. Melo JV. The molecular biology of chronic myeloid leukaemia. Leukemia 1996 10 : 751 6.
18. Aurer I, Butturini A, Gale RP. BCR/ABL rearrangements in children with Philadelphia chromosome-positive chronic myelogenous leukemia. Blood 1991 78 : 2407 10.
19. Ruiz-Argüelles GJ, Garcés-Eisele J, Reyes-Núñez V, Ruiz-Delgado GJ. Frequencies of the breakpoint cluster region types of the BCR/ABL fusion gene in Mexican Mestizo patients with chronic myelogenous leukemia. Rev Invest Clin 2004 56 : 605 8.
20. Arana-Trejo RM, Ruíz Sánchez E, Ignacio-Ibarra G, et al. BCR/ABL p210, p190 and p230 fusion genes in 250 Mexican patients with chronic myeloid leukaemia (CML). Clin Lab Haematol 2002 24 : 145 50.
21. Berger U, Maywald O, Pfirrmann M, et al. Gender aspects in chronic myeloid leukemia: long-term results from randomised studies. Leukemia 2005 19 : 984 9.
22. Bain BJ. Cytogenetic and molecular genetic aspects of eosinophilic leukaemias. Br J Haematol 2003 122 : 173 9.
23. Cilloni D, Messa F, Martinelli G, et al. Saglio GWT1 transcript amount discriminates secondary or reactive eosinophilia from idiopathic hypereosinophilic syndrome or chronic eosinophilic leukemia. Leukemia 2007 21 : 1442 50.
24. Mahmoud SF, McCobb DP. Regulation of Slo potassium channel alternative splicing in the pituitary by gonadal testosterone. J Neuroendocrinol 2004 16 : 237 43.
25. Thakur MK, Mani ST. Estradiol regulates APP mRNA alternative splicing in the mice brain cortex. Neurosci Lett 2005 381 : 154 7.
26. Zhu N, Eghbali M, Helguera G, Song M, Stefani E, Toro L. Alternative splicing of Slo channel gene programmed by estrogen, progesterone and pregnancy. FEBS Lett 2005 579 : 4856 60.
27. Casper A, Van Doren M. The control of sexual identity in the Drosophila germline (Review). Development 2006 133 : 2783 91.
28. Shepherd P, Suffolk R, Halsey J, Allan N. Analysis of molecular breakpoint and m-RNA tran-scripts in a prospective randomized trial of interferon in chronic myeloid leukaemia: no corre-lation with clinical features, cytogenetic response, duration of chronic phase, or survival. Br J Haematol 1995 89 : 546 54.
29. Melo JV, Hochhaus A, Yan XH, Goldman JM. Lack of correlation between ABL-BCR expression and response to interferon-alpha in chronic myeloid leukaemia. Br J Haematol 1996 92 : 684 6.
30. Goh HG, Hwang JY, Kim SH, Lee YH, Kim YL, Kim DW. Comprehensive analysis of BCR/ABL transcript types in Korean CML patients using a newly developed multiplex RT-PCR. Transl Res 2006 148 : 249 56.
31. Wacker MJ, Godard MP, McCabe EH, Donnelly JE, Kelly JK. Sex difference in the association of the anngiotensin converting enzyme I/D polymorphism and body mass index. Med Sci Monit 2008 14 : 353 7.
32. Hull J, Campino S, Rowlands K, et al. Identification of common genetic variation that modulates alternative splicing. PloS Genet 2007 3 : 1009 18.